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What is important for Data Protection  
in science in the future? 
General and specific changes in data protection for scientific use 
resulting from the EU General Data Protection Regulation1 
 
 
By Katrin Schaar 




On 14th April the General Data Protection Regulation (GDPR) wa s passed by the EU 
Parliament. 2 , 3  It came into force in May 2016 and will – after possible modification of 
national legislation – become directly applicable law in the EU member states. The GDPR 
replaces the European Data Protection Directive (DPD) from 19954 as well as the individual 
national data protection laws within the EU member states. 
The GDPR comprises in total 99 articles which are explained in 173 Recitals. One goal of the 
new regulation is to provide an appropriate data protection framework for the current 
challenges resulting from new technological developments, such as cloud computing and big 
data. Furthermore, the aim is to harmonize data protection regulation in EU member states. 
With the GDPR a unified regulatory structure for the whole of the European Union has been 
created, only certain well-defined aspects of which can be expanded or refined by the member 
states. 
In contrast, the Data Protection Directive from 1995 gave the member states much more 
leeway. With the new regulations there will be a single unified European data protection law, 
which differs in some parts significantly from the old directive. Moreover, in the area of 
                                                          
1 This paper was originally published in German as RatSWD Working Paper 257/2016. 
2 Regulation (EU) 2016/679 of the European Parliament and of the Council of 27 April 2016 on the protection of natural 
persons with regard to the processing of personal data and on the free movement of such data, and repealing Directive 
95/46/EC (General Data Protection Regulation), 2016. 
3 See also the condensed version of this paper in the Zeitschrift für Datenschutz (Schaar, K., 2016). 
4 Directive 95/46/EC of the European Parliament and of the Council of 24 October 1995 on the protection of individuals with 
regard to the processing of personal data and on the free movement of such data, 1995. 
2 
research, certain questions need to be reevaluated with regard to data protection and research 
practice needs to be modified accordingly. 
That the personal data of participants of scientific studies need to be protected is completely 
uncontested, and this is also the case within the scientific community. In this spirit, the 
German Data Forum (Rat für Sozial- und Wirtschaftsdaten, RatSWD), an institution which 
aims to improve the scientific data infrastructure for empirical research, stated during the 
negotiations regarding the GDPR that data protection is essential for empirical research. 
Participants of scientific studies need to be sure that their anonymity will be guaranteed, 
because otherwise it could lead to a loss of trust and less acceptance for scientific research 
(RatSWD, 2015, p. 2). 
This loss of trust could have a negative influence on people’s willingness to provide surveys 
with, for example, sensitive data, such as political or religious orientation, or to take part in 
medical studies if they cannot be sure that this information is kept completely confidential. In 
the area of survey research, the new regulations can also be of help, since “the reliable 
regulation of ethical and data protection issues has significant relevance to research practice, 
especially with respect to a generally falling willingness to participate in such studies” 
(Kämper, 2016, p. 6). 
Potential study participants could be even more skeptical if they are also asked to provide 
genetic data or geo-data which could be traced back to an individual even without disclosing 
common identification items (name, address, date of birth). Kämper (2016) points out 
uncertainties which require a rethinking of research ethics and data protection. Various 
phenomena contribute to the need for new regulation: requirements by scientific journals 
regarding documentation of data used for analysis; technological developments in the area of 
big data and data linkage increasing the possibility of de-anonymization; more 
interdisciplinary research and the increase of secondary data usage, which could be in conflict 
with the informed consent originally given for the primary data usage (Kämper, 2016, p. 4). 
The framework for data protection and the protection of participants are therefore important 
for scientific research. This is true for the traditional qualitative and quantitative empirical 
research which processes personal data, be it from social science, psychology or medicine, 
and applies all the more to the new research area of “personalised” medicine, to open access 
and big data, as well as to the increasingly widespread multi- and interdisciplinary research 
projects, in which medical, socioeconomic and genetic data are collected and analysed. 
3 
General changes with relevance for research 
A large number of changes result from the GDPR (Wytibul, 2016b) which have a direct 
influence on research using personal data. Although the processing of personal data for 
research or for statistical purposes is in some ways privileged (Die Bundesbeauftragte für den 
Datenschutz und die Informationsfreiheit, 2016, p. 31), scientific research still needs take 
adequate measures to guarantee the civil liberties of the study participants. 
 
Higher penalties for privacy breaches 
In general the GDPR increases sanctions for breaches against the regulation. The current data 
protection law of Germany (Bundesdatenschutzgesetz, BDSG) in §43 allows fines up to 
€300,0005, whereas the new regulation allows fines of up to €10 million or €20 million for the 
controllers and up to two or four percent of the total worldwide annual turnover of the 
preceding financial year for companies (GDPR, art. 83, para. 4,5). 
 
Responsibility 
The so-called ‘controller’ needs to ensure that the processing of data follows the rules of the 
regulation and also need to be able to demonstrate this compliance (GDPR, art. 5, para. 2). 
The ‘controller’ is “the natural or legal person, public authority, agency or other body which, 
alone or jointly with others, determines the purposes and means of the processing of personal 
data” (GDPR, art. 4, para. 7). This can be, for example, the research institution as represented 
by its director.  
The controller can and, in certain cases, must designate a data protection officer (GDPR, art. 
37).6 Unlike the German Data Protection Law, the data protection officer does not only have 
to work towards the compliance of the regulation (BDSG, art. 4g para. 1). Under the new 
regulation, data protection officers need to monitor the compliance with the regulation, train 
the staff and raise their awareness, advise the controllers regarding their policies and also 
oversee these policies. The data protection officer is also responsible for providing advice on 
the data protection impact assessment and monitoring its performance (GDPR, art. 39, para. 
1). This could lead to the data protection officers monitoring the applied practices of data use 
                                                          
5 Note that the fines have varied among the member states up to now. 
6 The GDPR provides an opening clause for the national specification of the regulation (GDPR, art. 37, para. 4). Whereas the 
GDPR does not require a data protection officer dependent on the number of persons involved in data processing, in 
Germany a data protection officer needs to be designated as soon as more than 20 staff members collect, process or use 
personal data (§4 f. BDGS). Because of the opening clause mentioned, this regulation could be kept in Germany. 
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more carefully, because they have a higher risk of liability than before (Wytibul, 2016a, 
p. 205). 
The new regulation is significant in the field of science because the officially designated data 
protection officer needs to be much more closely involved during the conception of research 
projects in order to be able to fulfill his duties. This raises the question of how this close 
involvement in the ethical approval process via ethics committees could be achieved in a 
reasonable way. Such ethics committees are well established in Germany for the medical 
sciences and psychology and their introduction is currently being discussed with regard to the 
social sciences (Kämper, 2016; Silverberg, 2016; Unger & Simon, 2016).7 
 
More transparency 
The GDPR requires more transparency in many areas (GDPR, art. 12–15). All information 
must be provided “in a concise, transparent, intelligible and easily accessible form, using clear 
and plain language” (GDPR, art. 12, para. 1). This applies, for example, to the information 
regarding the purposes of the data collection, the processing of the data, as well as any 
planned transfer of the personal data to third parties. Additionally, the participants need to be 
informed about their rights (GDPR, art. 13). 
For instance, information must be given to the participants about their right of access, 
including their “right to be forgotten” (GDPR, art. 17), and also about their right of 
rectification or erasure of their data (art. 13, para. 2b). Also the general right of access by the 
data subject has been strengthened (art. 15) and all information needs to be given in an easily 
understandable form. This leads to rigorous requirements for documentation, because without 
documentation the institutions, processing the data, cannot provide information about the 
transfer of data or the types of personal data that were collected, copies of which may even 
need to be handed out to the data subject. Although the information necessary to allow 
“informed consent” for participation in a research study is already supposed to be adapted to 
the target group, it will be a real challenge to provide understandable information about the 
existing research data as long as they are still connectable and not anonymised, unless specific 
regulations for science are established on a national level.  
                                                          
7 In the UK and the US, ethics committees are already established also for the social sciences. In Germany there are 
tendencies to establish them, but they are not yet widespread (see also Oellers and Wegner, 2009). 
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Data Protection Impact Assessment aims to minimise risks 
The GDPR distinguishes various risks which the data users can be exposed to and in certain 
cases requires a “data protection impact assessment” (GDPR, art. 35). In particular, this needs 
to be carried out if new technologies are applied or certain categories of data (sensitive data) 
are processed. These include “personal data revealing racial or ethnic origin, political 
opinions, religious or philosophical beliefs, or trade union membership, and the processing of 
genetic data, biometric data for the purpose of uniquely identifying a natural person, data 
concerning health or data concerning a natural person's sex life or sexual orientation” (GDPR, 
art. 9, para. 1).  
These core data, however, are frequently collected and processed in social scientific and 
medical studies. With respect to the new law, a data protection impact assessment needs to be 
carried out by the controller in cooperation with the data protection officer (GDPR, art. 35, 
para. 2). In the impact assessment, the purposes and the method of the processing of the data 
need to be described, the “necessity and proportionality of the processing operations in 
relation to the purposes” need to be assessed, the “risks to the rights and freedoms of the data 
subjects” need to be evaluated, and “measures envisaged to address the risks, including 
safeguards, security measures and mechanisms to ensure the protection of personal data” need 
to be described (GDPR, art. 35, para. 7). 
 
Research-specific changes 
Informed Consent but with expanded purpose limitation 
Under the new law, participants still need to be informed about the purposes and modalities of 
the data collection and processing (GDPR, art.12). The consent must be given freely and can 
be withdrawn at any time (GDPR, art. 7). The consent can be made “by a written statement, 
including by electronic means, or an oral statement”, which needs to be documented (GDPR, 
recital 32). A lack of response or inactivity do not constitute consent (ibid.). Thus, a central 
requirement of the GDPR is active consent for the data usage on a freely given basis and after 
detailed information about the purposes of the data collection. 
A substantial change in the GDPR is the definition of “purpose limitation”. The 1995 data 
protection directive states that the processing of personal data “must be adequate, relevant and 
not excessive in relation to the purposes for which they are processed; whereas such purposes 
must be explicit and legitimate and must be determined at the time of collection of the data” 
(DPD, recital 28). The new regulation, however, stipulates that data can be “collected for 
specified, explicit and legitimate purposes and not further processed in a manner that is 
incompatible with those purposes; further processing for archiving purposes in the public 
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interest, scientific or historical research purposes or statistical purposes shall (…) not be 
considered to be incompatible with the initial purposes (‘purpose limitation’).“ (GDPR, art. 5, 
para. 1b)8 
Furthermore, the recitals of GDPR mention the possibility of consenting to data usage for 
certain areas of scientific research: “It is often not possible to fully identify the purpose of 
personal data processing for scientific research purposes at the time of data collection. 
Therefore, data subjects should be allowed to give their consent to certain areas of scientific 
research when in keeping with recognised ethical standards for scientific research. Data 
subjects should have the opportunity to give their consent only to certain areas of research or 
parts of research projects to the extent allowed by the intended purpose “(GDPR, recital 33) 
In a first statement, the RatSWD interpreted this as a positive change for science (RatSWD, 
2015). The consent form for participants of scientific studies could therefore define certain 
areas which are larger than the research question originally described. This would also be an 
opportunity for qualitative research, in which the research question is developed during 
fieldwork in the context of the theoretical sampling (Glaser, 1992; Strauss & Corbin, 1990), to 
ensure compliance with data protection regulation through appropriate phrases in the consent 
forms. Thus, participants could be informed about the general research question and the 
procedure by which new research questions could emerge during the research process.9 
Consent forms should contain opt-in/opt-out possibilities, so that participants can decide how 
extensively their data can be used and, in a research context, how they can be transferred to 
other scientists or linked with other information. If subsequently the data are to be used in a 
different context to the original one, participants still need to be informed (GDPR, art. 14, 
para. 4). Overall, the regulation of purpose limitation is not very precise, because the point at 
which further processing of data becomes contrary to the original purpose is not well defined 
(see Roßnagel & Nebel, 2016, p. 6). 
                                                          
8 The difference to the German law is even larger than that to the DPD: The German Data Protection Law allows the usage 
and further processing only if the data subject has given his or her explicit consent (BDSG para.14 (2)(2). The BDSG also 
provides exceptions for scientific research (para. 14 (2)(9)). 
9 The problem of obtaining informed consent for qualitative research projects is mentioned by Kämper (2016, p. 7) and 
Unger and Simon (2016, pp. 10 f.). The argument of Unger and Simon (ibid., p. 11), that one could not ask all fans of a 
football game for their consent in the context of participating observation, is– in my opinion –  not convincing. One could 
record such observations in field notes in an anonymous way, which would then be data to which the GDPR would not be 
applicable. As soon as the observation is personalised or individuals are interviewed, the participants need to be informed 
and need to consent actively (see GDPR, recital 32 and art. 13). See also the instructive working paper of the RatSWD 
working group “Data protection and qualitative research”, which deals in particular with the data protection compliance of 
consent forms for the processing and further use of qualitative interviews. It also provides examples for consent forms for 
qualitative interviews (Liebig et al., 2014).  
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In all cases of further processing of data for research purposes “in accordance with the 
regulation the rights and freedoms of the data subject” should be ensured (GDPR, art. 89, 
para. 1). In particular, this means that technical and organisational measures must be applied 
which guarantee that the data subject is not identifiable. 
 
Anonymisation and pseudonymisation for long-term scientific data processing 
The question as to whether scientific data need to be completely anonymized, which was 
discussed during the development of the GDPR, has also been resolved. Contrary to the 
stipulation in the draft of the GDPR, complete anonymization of data is no longer explicitly 
required. Such a requirement would have been problematic for, say, longitudinal research 
projects, because it would not have been possible to merge the new data with pre-existing data 
from the same participants (RatSWD, 2015). 
In fact, the pseudonymisation of participants’ data, alongside anonymization, is a possible 
way of processing the data, as long as further processing “does not permit or no longer 
permits the identification of data subjects” (GDPR, art. 89, para. 1). However, it must be 
considered whether it really is no longer possible to identify a person. To achieve this 
“account should be taken of all objective factors, such as the costs of and the amount of time 
required for identification, taking into consideration the available technology at the time of 
the processing and technological developments.“ (GDPR, recital 26) 
This corresponds with the maxim of German data protection law which does not require 
complete but only effective removal of personal references. Paragraph 3(6) of the BDSG 
defines ‘anonymisation’ as “the modification of personal data in such a manner that 
particulars about an individual cannot matched to a specific or identifiable person, or only 
with a disproportionate investment of time, cost and labour.” (BDSG, para. 3 (6))10  
Correspondingly, when pseudonymisation and anonymisation procedures are chosen – for 
instance within the data protection impact assessment mentioned – the concrete risks of de-
anonymisation, including economic and technical factors, need to be taken into account. In 
this regard, the rapid technological development needs to be considered, because a procedure 
which guarantees a sufficient standard of anonymization at the moment might not guarantee 
that same protection a few years hence. Thus, anonymisation procedures need to involve a 
                                                          
10 Translation by the author. Original text: „Anonymisieren das Verändern personenbezogener Daten derart, dass die 
Einzelangaben über persönliche oder sachliche Verhältnisse nicht mehr oder nur mit einem unverhältnismäßig großen 
Aufwand an Zeit, Kosten und Arbeitskraft einer bestimmten oder bestimmbaren natürlichen Person zugeordnet werden 
können.“ 
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form of “protection buffer” against potential risks in the future. The GDPR explicitly 
indicates: “The principles of data protection should (…) not apply to anonymous information, 
namely information which does not relate to an identified or identifiable natural person or to 
personal data rendered anonymous in such a manner that the data subject is not or no longer 
identifiable.” (GDPR, recital 26) This means that in as far as it is not possible to link the 
research data to the participants, the regulation no longer applies. 
As long as the persons are no longer identifiable, data can be processed in a scientific context 
(GDPR, art. 89, para. 1). In this state, the data are not personal data anymore, because they 
cannot be connected to a natural person (GDPR, art. 4, para. 1) and therefore they are not 
subject to the protection of the regulation anymore. A new and interesting aspect is that even 
data with a pseudonym are not considered as personal data as long as technical and 
organisational measures are applied such that re-identification is not possible. With this 
definition, data can be used in various research projects and can be connected across time 
series (RatSWD, 2015). 
 
Research with sensitive data in a legal grey area 
Personalised medicine is one of the large new research areas for which the use of sensitive 
data is essential. It is supported by the research programmes of the EU and also via research 
grants within Germany. Personalised medicine as well as “enhancing the use of databases and 
electronic health records as data sources for trials and knowledge transfer” is promoted by the 
European Research Program Horizon 2020 (European Commission, 30.11.2011) and is also 
addressed in numerous other calls (Horizon 2020: Work Programme 2016-2017, 2016). In 
addition, the German Government is financing personalised and individualised medicine via 
the German Gesundheitsrahmenprogramm (Framework for Health) (BMBF, 2010).  
However, personalised medicine depends in many cases on genetic analyses which make it 
possible to estimate which therapies could have an effect on humans due to their genetic 
disposition (see Schaar, P., 2016, p. 33). The GDPR defines genetic data in Article 4, 
Paragraph 13 as follows: “‘genetic data’ means personal data relating to the inherited or 
acquired genetic characteristics of a natural person which give unique information about the 
physiology or the health of that natural person and which result, in particular, from an analysis 
of a biological sample from the natural person in question" (GDPR, art. 4, para. 13). 
This means – at least if they are gathered in detail – that genetic data in principle cannot be 
anonymised, because the information which they contain are per se personal (see Hardenberg, 
2014, p. 117). Genetic data are unique even if all other identifiable attributes are deleted, since 
it is in principle possible to connect them to the person to whom they belong (Arning, 
9 
Claerhout, Egermann, Forgó, & Krügel, 2011; Gymrek, McGuire, Golan, Halperin, & Erlich, 
2013). Therefore genome research, and thus also personalised medicine, is inherently 
associated with risk in terms of data protection. According to Article 9 of the GDPR, 
particularly sensitive data can be collected and processed as long as the individual agrees, or 
if they are collected and processed for purposes of general healthcare, for example, in the 
context of scientific projects as well as for “studies conducted in the public interest in the area 
of public health” (GDPR, recital 53).  
 
Open access and big data allowed but not well-defined 
The expectations of acquiring new knowledge by merging and analyzing huge amounts of 
data are high. The explanatory power increases if scientific questions can be pursued across 
multiple studies. Moreover, it is in the spirit of science if results which are obtained by 
research projects financed by the public are available for further research questions and for 
reanalysis. Open access or open science are therefore supported and now even required by 
various institutions. The European Commission intends to introduce an experimental phase 
for the open use of scientific data (Horizon 2020: Work Programme 2016–2017, 2016).11 
The guidelines for the research programs of the German Federal Ministry of Education and 
Research and the German Research Foundation (DFG) also increasingly require open access 
not only for publications but also for the data collected. With regard to big data, there are 
approaches involving the merging of scientific data from research studies with data from other 
sources such as health or social insurance. The European Regulation assumes that there is an 
added value for scientific insight into illnesses and social circumstances, therefore and “in 
order to facilitate scientific research, personal data can be processed for scientific research 
purposes, subject to appropriate conditions and safeguards set out in Union or Member State 
law.“ (GDPR, recital 157) 
The GDPR does not make clear statements regarding the merging of data. As long as data are 
completely anonymised or pseudonymised in such a way that a person can no longer be 
identified, there is probably no risk for the participants of scientific studies and also no 
                                                          
11 “A novelty in Horizon 2020 is the Pilot on Open Research Data, which aims to improve and maximise access to and reuse 
of research data generated by projects. While certain Work Programme parts and calls have been explicitly identified to 
participate in the Pilot on Open Research Data, individual projects funded under the other Work Programme parts and calls 
can choose to participate in the Pilot on a voluntary basis. Participating projects will be required to develop a Data 
Management Plan (DMP), in which they will specify what data the project will generate, whether and how it will be 
exploited or made accessible for verification and reuse, and how it will be curated and preserved.” (Horizon 2020: Work 
Programme 2016–2017, 2016, p.6) 
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contradiction to the data protection regulations. Technical measures should “ensure that by 
default personal data are not made accessible without the individual's intervention to an 
indefinite number of natural persons.” (GDPR, art. 25, para. 2) More or less automated access 
to mass data or their analysis with a “joker request”, by which multiple datasets which are 
homogeneous in certain aspects can be selected, will not be possible. 
However, the question of how one can deal with “open access” or “scientific use” for genetic 
data remains unresolved. At the same time, not just medical research questions, but also 
questions with relevance to the social sciences are becoming more important, for instance 
regarding the educational attainment or the genetic conditions for well-being (Okbay, 
Baselmans et al., 2016; Okbay, Beauchamp et al., 2016; Rietveld et al., 2013). Data from 
various research projects have already been merged within international biobanks (e.g. 
GERA, n.d.; UK Biobank Limited, n.d.) in order to obtain results about genetic disposition, 
because patterns and relationships can only be identified on the basis of more than 100.000 
observations. However, the problem is that genetic data – also according to the deliberations 
of the European Council – are personal data (see above). They are in principle re-identifiable 
and therefore the question arises as to whether they should be transferred to biobanks with far-
reaching usage by several data users. Also the implementation of the “right to be forgotten” 
(GDPR, art. 17) presents a real challenge for this category of data due to the re-identification 
possibilities, which in the future will presumably become technically more and more feasible. 
Although it is possible to allow the transfer of genetic data to biobanks with the informed 
consent of the participants of scientific studies, it is still unclear how the civils rights of the 
participants can really be protected. For example, some biobanks – such as the UK biobank – 
place no restrictions on commercial usage. Moreover, it has not been empirically tested how 
well-protected the data are against re-identification and the merging with other information. 
 
Outlook: Specific implementation open 
Overall, it can be concluded that the GDPR is vague with regard to precise statements on the 
usage of new technologies and big data processing. In this respect it fails to live up to its own 
aspirations. Roßnagel and Nebel (2016, p. 6) see the biggest deficiency of the Regulation in 
the lack of regulation which addresses or even removes the risks resulting from the significant 
new challenges of modern information technology such as big data, ubiquitous computing 
(internet of things), cloud computing and others. The regulations are in part formulated in an 
abstract way and 70 flexibility clauses need to be specified on the national level (ibid., p.3). 
11 
One of the clauses concerns scientific research directly: In Article 89 the GDPR gives the 
Member States the opportunity to define “safeguards and derogations” for scientific research. 
These concern, for instance, derogations covering the right of access by the data subject 
(GDPR, art. 15), the right to rectification (GDPR, art. 16), the right to restriction of processing 
(GDPR, art. 18), and the right to object (GDPR, art. 21). Thus, the provisions can be made 
wider or narrower and can be specified more exactly. 
The member states can also define rules for the use of especially sensitive data: “Member 
States should be allowed to maintain or introduce further conditions, including limitations, 
with regard to the processing of genetic data, biometric data or data concerning health. 
However, this should not hamper the free flow of personal data within the Union when those 
conditions apply to cross-border processing of such data.” (GDPR, recital 53) 
Not only companies (Wytibul, 2016b), but also research institutions need to take into account 
the new provisions of the GDPR with respect to their research projects and need to revise the 
associated processes. The current debate about the introduction of ethics committees in the 
social sciences, in which data protection is supposed to be integrated as one aspect, has come 
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